The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
Teva Pharmaceutical Industries sues CMS over Medicare drug pricing negotiations policy, claiming agency has unchecked ...
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare ...
CMS has named 15 additional prescription drugs, including diabetes medication Ozempic, for price negotiations under the Inflation Reduction Act. This marks the second round of negotiations aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback